Substrate Envelope Based Design of New HIV-1 Protease Inhibitors Active Against Drug-Resistant HIV-1

Yee, Kevin E.

Student Work

Substrate Envelope Based Design of New HIV-1 Protease Inhibitors Active Against Drug-Resistant HIV-1

Public

With over 30 different Human Immunodeficiency Virus drugs approved by the FDA, drug resistance is still a major problem. This experiment suggested a new general structure-based design for drug discovery based on the substrate envelope hypothesis in order to successfully design and synthesize a series of novel HIV-1 protease inhibitors. The design inhibitors utilize the 2-ethylbutyl group as new high affinity P1129140 ligands. The designed compounds showed highly potent inhibitory activity against wild-type and a panel of MDR HIV-1 Protease variants. Further development of these protease inhibitors may lead to more effective treatments against drug-resistant HIV-1.

This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.

Creator